Nirrin Technologies received U.S. Patent 12,222,279 B2 for its advanced flow-cell technology for in-bioprocess analytics. This patent expands Nirrin’s capabilities…
The pathogen Clostridioides difficile, commonly known as C. diff, has emerged as a leading cause of healthcare-associated infectious diarrhea, affecting…
In a groundbreaking study published in JAMA Network Open, researchers have highlighted critical insights concerning the prognostication of comatose patients…